

🔬Causal Models Need Causal Data - Xaira’s X-Cell model for Drug Discovery (Bo Wang & Ci Chu, Chief Discovery Officer & Chief AI Scientist)
Bet on information If test loss flatlines after 1.5B parameters while training loss continues to drop as you scale, that tells you that your model is limited by the amount of information in your data. Training on a single, smallish data set exposed an information gap: the 3.1B model falls off the scaling trend.…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Latent Space: The AI Engineer Podcast
See all episodes →
🔬Scaling Past Informal AI - Carina Hong, Axiom Math

🔬Bio-security is an AI Arms Race - Eric Nguyen (CEO, Radical Numerics)

Runway’s WorldPrompt and the Engineering of Real-Time Worlds
Similar episodes from other shows
More like Latent Space: The AI Engineer Podcast →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech

EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine

Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier

Big Pharma Fails 50% of the Time in Phase Three. AI Can Fix That | Vin Singh, BullFrog AI
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.